Raised high sensitivity Troponin T (Hs-TnT) assays in non-ACS medical admissions and long term outcomes

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Seoidin Mckittrick

Mayo University Hospital Castlebar, Castlebar (Ireland)

6 More presentations in this session

Presentation thumbnail

Discussant - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling

Presentation thumbnail

Circulating MicroRNA profile in coronary artery disease

Mr S. Kumar (New Delhi, IN)

Abstract Slides Video

Presentation thumbnail

The product of bilirubin and trigliseride is the most significant predictor of severe FIB-4 index of liver disease in cardiac patients

Doctor S. Celik (Istanbul, TR)

Abstract Slides Video

Presentation thumbnail

Association of interleukin gene polymorphisms with coronary artery disease severity

Miss M. Liu (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Troponin elevation and vascular involvement post-COVID-19

Doctor A. Kamdar (Glasgow, GB)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (2) - Emerging biomarkers and molecular mechanisms in cardiovascular disease: from inflammation to remodelling

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

High-Sensitivity Troponin-T and heart failure risk in individuals with suspected acute coronary syndrome

Congress Presentation

Assay of macrotroponin I not complexed with troponin T: effect on the performance of troponin T to predict myocardial infarction

Congress Presentation

Long-term prognosis associated with undetectable high-sensitivity cardiac troponin T concentrations in the emergency department

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources